Repositorio Dspace

In Vitro Evaluation of Novel Resin-Modified Calcium Silicate Cements for Minimally Invasive Vital Pulp

Mostrar el registro sencillo del ítem

dc.contributor.author Rodríguez-Lozano, Francisco-Javier
dc.contributor.author Pérez-Guzmán, Nuria
dc.contributor.author García-Ríos, Paula
dc.contributor.author García-Bernal, David
dc.contributor.author Mora, Alejandro
dc.contributor.author López-García, Sergio
dc.date.accessioned 2026-03-10T11:55:50Z
dc.date.available 2026-03-10T11:55:50Z
dc.date.issued 2026-02
dc.identifier.citation Rodríguez-Lozano FJ, Pérez-Guzmán N, García-Rios P, García-Bernal D, Mora A, López-García S. In Vitro Evaluation of Novel Resin-Modified Calcium Silicate Cements for Minimally Invasive Vital Pulp Therapy. International Dental Journal. febrero de 2026;76(1):109299. doi:10.1016/j.identj.2025.109299
dc.identifier.issn 0020-6539
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/25363
dc.description.abstract OBJECTIVES: This study aimed to evaluate the biological effects of one conventional calcium silicate-based cement (MTA Angelus) and three resin-modified formulations (TheraCal PT, TheraBase Ca, and TheraCal LC) on human dental pulp stem cells (hDPSCs), focusing on cytocompatibility, cellular behaviour, and odontogenic/mineralization potential. METHODS: hDPSCs were cultured with material extracts at different dilutions (1:1, 1:2, 1:4). Cytocompatibility was assessed using MTT assay, wound-healing migration, and immunofluorescence for cytoskeletal organization. Cell adhesion and morphology were examined by SEM, while material composition was analysed by EDX. Odontogenic/osteogenic differentiation was evaluated through qRT-PCR for ALP, RUNX2, COL1A1, DSPP, BSP, and ON at 3 and 7 days, and extracellular matrix mineralization was quantified by Alizarin Red S staining at 21 days. Results were compared with untreated controls (P < .05). RESULTS: MTA Angelus exhibited the most favourable biological performance (P < .001), with high cytocompatibility, strong upregulation of odontogenic genes, and abundant mineralized nodule formation. TheraCal PT showed intermediate outcomes, with higher gene expression and mineralization capacity than TheraBase Ca (P < .001). TheraBase Ca provided the best cytocompatibility and cell adhesion among resin-modified cements (P < .05) but induced moderate differentiation and mineralization. In contrast, TheraCal LC displayed the lowest cell viability, impaired migration, and limited mineralization potential (P < .001). CONCLUSION: MTA Angelus remains the benchmark material for vital pulp therapy due to its robust bioactivity, while TheraCal PT and TheraBase Ca emerge as promising resin-modified alternatives, each with distinct biological advantages. TheraCal LC, however, demonstrated limited cytocompatibility and regenerative potential. CLINICAL SIGNIFICANCE: These findings highlight the importance of material selection in vital pulp therapy. Resin-modified calcium silicate cements may serve as alternatives, but MTA Angelus continues to offer the most predictable biological outcomes for pulp preservation and repair.
dc.language.iso eng
dc.publisher ELSEVIER
dc.rights Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subject.mesh Humans
dc.subject.mesh Calcium Compounds/pharmacology/chemistry
dc.subject.mesh Silicates/pharmacology/chemistry
dc.subject.mesh Dental Pulp/cytology/drug effects
dc.subject.mesh Stem Cells/drug effects
dc.subject.mesh In Vitro Techniques
dc.subject.mesh Dental Cements/pharmacology
dc.subject.mesh Materials Testing
dc.subject.mesh Cell Differentiation/drug effects
dc.subject.mesh Drug Combinations
dc.subject.mesh Aluminum Compounds/pharmacology
dc.subject.mesh Cells, Cultured
dc.subject.mesh Cell Adhesion/drug effects
dc.subject.mesh Resin Cements/pharmacology
dc.subject.mesh Cell Movement/drug effects
dc.subject.mesh Odontogenesis/drug effects
dc.subject.mesh Osteogenesis/drug effects
dc.subject.mesh Bismuth
dc.subject.mesh Oxides
dc.title In Vitro Evaluation of Novel Resin-Modified Calcium Silicate Cements for Minimally Invasive Vital Pulp
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 41308279
dc.relation.publisherversion https://linkinghub.elsevier.com/retrieve/pii/S002065392508582X
dc.type.version info:eu-repo/semantics/publishedVersion
dc.identifier.doi 10.1016/j.identj.2025.109299
dc.journal.title International Dental Journal
dc.identifier.essn 1875-595X


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta